A molecular profile of the tumour is characterized by the absence or low level of microsatellite instability (MSI), rare loss of heterozygosity (LOH), retained expression of RUNX3, amplifications of 17q, 19q and 20q, and high expression of low-molecular-weight cyclin E isoforms16. This evidence concerns the gene CCNE1 and neoplasm.